Robert E. Jordan

8.1k total citations · 1 hit paper
109 papers, 6.4k citations indexed

About

Robert E. Jordan is a scholar working on Hematology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Robert E. Jordan has authored 109 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Hematology, 29 papers in Surgery and 23 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Robert E. Jordan's work include Platelet Disorders and Treatments (26 papers), Monoclonal and Polyclonal Antibodies Research (22 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (18 papers). Robert E. Jordan is often cited by papers focused on Platelet Disorders and Treatments (26 papers), Monoclonal and Polyclonal Antibodies Research (22 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (18 papers). Robert E. Jordan collaborates with scholars based in United States, Canada and Belgium. Robert E. Jordan's co-authors include R. J. Dwayne Miller, Jason R. Dwyer, Bradley J. Siwick, Randall J. Brezski, Robert Rosenberg, G.M. Oosta, Barry S. Coller, R D Rosenberg, Harlan F. Weisman and Mary Ann Mascelli and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Physical Review Letters.

In The Last Decade

Robert E. Jordan

108 papers receiving 6.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An Atomic-Level View of Melting Using Femtosecond Electron Diffraction

2003 674 citations Bradley J. Siwick, Jason R. Dwyer et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Robert E. Jordan	1.4k	1.4k	1.3k	1.0k	989	109	6.4k
F. J. Walker	2.2k 1.6×	287 0.2×	271 0.2×	918 0.9×	570 0.6×	204	9.6k
Hanno Riess	727 0.5×	1.3k 0.9×	3.1k 2.4×	67 0.1×	1.5k 1.5×	319	13.5k
R. J. Simes	106 0.1×	902 0.7×	3.1k 2.4×	1.0k 1.0×	1.3k 1.3×	144	12.0k
Steven A. Curley	236 0.2×	446 0.3×	8.0k 6.2×	109 0.1×	2.8k 2.8×	309	24.4k
Jun Suzuki	314 0.2×	360 0.3×	555 0.4×	132 0.1×	2.1k 2.1×	241	5.5k
Alnawaz Rehemtulla	781 0.6×	191 0.1×	477 0.4×	167 0.2×	5.1k 5.2×	232	13.1k
Yves Boucher	171 0.1×	155 0.1×	1.2k 1.0×	102 0.1×	6.8k 6.8×	111	17.0k
John D. Martin	165 0.1×	289 0.2×	922 0.7×	52 0.1×	2.9k 3.0×	171	10.0k
Balázs Győrffy	421 0.3×	186 0.1×	1.1k 0.8×	2.1k 2.1×	14.6k 14.8×	504	26.3k
Klaus Pantel	942 0.7×	239 0.2×	3.3k 2.6×	100 0.1×	20.9k 21.2×	721	54.1k

Countries citing papers authored by Robert E. Jordan

Since Specialization

Citations

This map shows the geographic impact of Robert E. Jordan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E. Jordan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E. Jordan more than expected).

Fields of papers citing papers by Robert E. Jordan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert E. Jordan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E. Jordan. The network helps show where Robert E. Jordan may publish in the future.

Co-authorship network of co-authors of Robert E. Jordan

This figure shows the co-authorship network connecting the top 25 collaborators of Robert E. Jordan. A scholar is included among the top collaborators of Robert E. Jordan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert E. Jordan. Robert E. Jordan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fan, Xuejun, et al.. (2018). Proteolytic single hinge cleavage of pertuzumab impairs its Fc effector function and antitumor activity in vitro and in vivo. Breast Cancer Research. 20(1). 43–43. 17 indexed citations

Biancheri, Paolo, Randall J. Brezski, Antonio Di Sabatino, et al.. (2015). Proteolytic Cleavage and Loss of Function of Biologic Agents That Neutralize Tumor Necrosis Factor in the Mucosa of Patients With Inflammatory Bowel Disease. Gastroenterology. 149(6). 1564–1574.e3. 104 indexed citations

Zhang, Ningyan, Robert E. Jordan, & Zhiqiang An. (2015). Tumor evasion of humoral immunity mediated by proteolytic impairment of antibody triggered immune effector function. OncoImmunology. 5(5). e1122861–e1122861. 2 indexed citations

Fan, Xuejun, Randall J. Brezski, Hui Deng, et al.. (2014). A Novel Therapeutic Strategy to Rescue the Immune Effector Function of Proteolytically Inactivated Cancer Therapeutic Antibodies. Molecular Cancer Therapeutics. 14(3). 681–691. 18 indexed citations

Kinder, Michelle, Allison R. Greenplate, Katharine D. Grugan, et al.. (2013). Engineered Protease-resistant Antibodies with Selectable Cell-killing Functions. Journal of Biological Chemistry. 288(43). 30843–30854. 31 indexed citations

Brezski, Randall J., Jennifer L. Luongo, Mary Ryan, et al.. (2008). Human Anti-IgG1 Hinge Autoantibodies Reconstitute the Effector Functions of Proteolytically Inactivated IgGs. The Journal of Immunology. 181(5). 3183–3192. 38 indexed citations

Hebeisen, Christoph T., Ralph Ernstorfer, Maher Harb, et al.. (2006). Femtosecond electron pulse characterization using laser ponderomotive scattering. Optics Letters. 31(23). 3517–3517. 58 indexed citations

Siwick, Bradley J., Jason R. Dwyer, Robert E. Jordan, & R. J. Dwayne Miller. (2003). Response to “Comment on ‘Ultrafast electron optics: Propagation dynamics of femtosecond electron packets’ ” [J. Appl. Phys. 94, 803 (2003)]. Journal of Applied Physics. 94(1). 807–808. 12 indexed citations

Palmerini, Tullio, Mark Nedelman, L E Scudder, et al.. (2002). Effects of abciximab on the acute pathology of blood vessels after arterial stenting in nonhuman primates. Journal of the American College of Cardiology. 40(2). 360–366. 25 indexed citations

10.

Fox, Floyd E., et al.. (2002). Effects of 2 Different Anti–Tumor Necrosis Factor–α Agents in a Primate Model of Subcutaneous Abscess Formation. The Journal of Infectious Diseases. 185(2). 204–213. 11 indexed citations

11.

Mascelli, Mary Ann, Neal S. Kleiman, Stanley J. Marciniak, et al.. (2000). Therapeutic heparin concentrations augment platelet reactivity: Implications for the pharmacologic assessment of the glycoprotein IIb/IIIa antagonist abciximab. American Heart Journal. 139(4). 696–703. 34 indexed citations

12.

Varner, Judith A., Marian T. Nakada, Robert E. Jordan, & Barry S. Coller. (1999). Inhibition of angiogenesis and tumor growth by murine 7E3, the parent antibodyof c7E3 Fab (abciximab; ReoProTM). Angiogenesis. 3(1). 53–60. 40 indexed citations

13.

Mascelli, Mary Ann, Stanley J. Marciniak, Ellen T. Lance, & Robert E. Jordan. (1998). Abciximab inhibits release of platelet granule constituents. Journal of the American College of Cardiology. 31. 24–25. 2 indexed citations

14.

Kleiman, Neil, et al.. (1998). Synergy of abciximab and ticiopidine in patients undergoing intracoronary stenting. Journal of the American College of Cardiology. 31. 238–238. 1 indexed citations

15.

Mascelli, Mary Ann, et al.. (1996). Rapid assessment of platelet inhibition using a modified whole blood aggregometer (aggrestat™) in PTCA patients receiving ReoPro™. Journal of the American College of Cardiology. 27(2). 361–361. 3 indexed citations

16.

Kleiman, Neal S., Albert E. Raizner, Robert E. Jordan, et al.. (1995). Differential inhibition of platelet aggregation induced by adenosine diphosphate or a thrombin receptor-activating peptide in patients treated with bolus chimeric 7E3 Fab: Implications for inhibition of the internal pool of GPIIb/IIIa receptors. Journal of the American College of Cardiology. 26(7). 1665–1671. 132 indexed citations

17.

Knight, David, Carrie Wagner, Robert E. Jordan, et al.. (1995). The immunogenicity of the 7E3 murine monoclonal Fab antibody fragment variable region is dramatically reduced in humans by substitution of human for murine constant regions. Molecular Immunology. 32(16). 1271–1281. 68 indexed citations

18.

Coller, Barry S., L E Scudder, Jürg H. Beer, et al.. (1991). Monoclonal Antibodies to Platelet Glycoprotein IIb/IIIa as Antithrombotic Agentsa. Annals of the New York Academy of Sciences. 614(1). 193–213. 124 indexed citations

19.

Jordan, Robert E., et al.. (1989). Antithrombin inactivation by neutrophil elastase requires heparin. The American Journal of Medicine. 87(3). S19–S22. 9 indexed citations

20.

Fb, Taylor, et al.. (1988). Antithrombin-III prevents the lethal effects of Escherichia coli infusion in baboons.. PubMed. 26(3). 227–35. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact